Hematologic Malignancy
Mycosis Fungoides Variant
CI-CAN-00008078Explore in graph →
Hematologic2 active trials
- NCIt
- C39644
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00008078Explore in graph →
Clinical trials
4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03011814 | Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma | recruiting | Phase 1 / Phase 2 | 78 | City of Hope Medical CenterOTHER | 1 | Jul 31, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Jul 31, 2026source: clinicaltrials